Publications de Sylvie BOYER
Primary tabs
Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa.
BMC Health Services Research
2022
;
22
(1)
:
303.
Sibling status, home birth, tattoos and stitches are risk factors for chronic hepatitis B virus infection in Senegalese children: A cross‐sectional survey.
Journal of Viral Hepatitis
2021
;
28
(11)
:
1515-1525.
https://onlinelibrary.wiley.com/doi/abs/10.1111/jvh.13589
Individual and healthcare supply-related barriers to treatment initiation in HIV-positive patients enrolled in the Cameroonian antiretroviral treatment access programme.
Health Policy and Planning
2021
;
36
(2)
:
137-148.
Long‐term clinical benefits of Sofosbuvir‐based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa.
Liver International
2020
;
40
(11)
:
2643-2654.
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).
BMC Infectious Diseases
2020
;
20
(1)
:
49.
Prevention and care of hepatitis B in the rural region of Fatick in Senegal : a healthcare workers’ perspective using a mixed methods approach.
BMC Health Services Research
2019
;
19
(1)
Cost‑Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV‑1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM).
PharmacoEconomics - Open
2019
;
Epub ahead of print.
Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial).
Journal of Acquired Immune Deficiency Syndromes - JAIDS
2019
;
80
(4)
:
375-385.
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
The Lancet HIV
2018
;
5
(3)
:
e116-e125.
Treatment interruption in HIV-positive patients followed up in Cameroon's antiretroviral treatment programme : individual and health care supply-related factors (ANRS-12288 EVOLCam survey).
Tropical Medicine & International Health
2018
;
23
(3)
:
315-326.
The value of specialist care—infectious disease specialist referrals—why and for whom? A retrospective cohort study in a French tertiary hospital.
European Journal of Clinical Microbiology and Infectious Diseases
2017
;
36
(4)
:
625-633.
http://link.springer.com/article/10.1007/s10096-016-2838-y
An Alternative Strategy of Preventive Control of Tick-Borne Relapsing Fever in Rural Areas of Sine-Saloum, Senegal.
American Journal of Tropical Medicine and Hygiene
2016
;
95
(3)
:
537-545.
The Point-of-Care Laboratory in Clinical Microbiology.
Clinical Microbiology Reviews
2016
;
29
(3)
:
429-447.
How do supply-side factors influence informal payments for healthcare? The case of HIV patients in Cameroon.
International Journal of Health Planning and Management
2016
;
31
(1)
:
E41--E57.
Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
Trials
2013
;
14
(1)
:
230.
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116).
AIDS Care
2010
;
22
(04)
:
441-451.